Burden of Premenstrual Dysphoric Disorder on Health-Related Quality of Life

Yang, Min; Wallenstein, Gene V.; Hagan, Michael; Guo, Amy; Chang, Joanne; Kornstein, Susan G.

doi:10.1089/jwh.2007.0417

Cited by 88 publications

(66 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This result is in agreement with previous studies showing that severe PMS/PMDD symptoms negatively affect QOL. [10][11][12][38][39][40] Some limitations of the present study must be addressed. First, we relied on self-reported information to exclude women with any physical or psychiatric comorbidity.…”

Section: Discussionmentioning

confidence: 99%

Validation of the Brazilian Portuguese version of the Premenstrual Symptoms Screening Tool (PSST) and association of PSST scores with health-related quality of life

Câmara

Köhler

Frey

et al. 2016

Rev. Bras. Psiquiatr.

View full text Add to dashboard Cite

Objective: To develop and validate a Brazilian Portuguese version of the Premenstrual Symptoms Screening Tool (PSST), a questionnaire used for the screening of premenstrual syndrome (PMS) and of the most severe form of PMS, premenstrual dysphoric disorder (PMDD). The PSST also rates the impact of premenstrual symptoms on daily activities. Methods: A consecutive sample of 801 women aged X 18 years completed the study protocol. The internal consistency, test-retest reliability, and content validity of the Brazilian PSST were determined. The independent association of a positive screen for PMS or PMDD and quality of life determined by the World Health Organization Quality of Life instrument-Abbreviated version (WHOQOL-Bref) was also assessed. Results: Of 801 participants, 132 (16.5%) had a positive screening for PMDD. The Brazilian PSST had adequate internal consistency (Cronbach's alpha = 0.91) and test-retest reliability. The PSST also had adequate convergent/discriminant validity, without redundancy. Content validity ratio and content validity index were 0.61 and 0.94 respectively. Finally, a positive screen for PMS/PMDD was associated with worse WHOQOL-Bref scores. Conclusions: These findings suggest that PSST is a reliable and valid instrument to screen for PMS/ PMDD in Brazilian women.Keywords: premenstrual dysphoric disorder; mood disorders; quality of life; premenstrual symptoms screening tool; psychiatry IntroductionFemale reproductive life events are often accompanied by physical and psychological challenges associated with a negative impact on women's functioning. 1 One such example is premenstrual syndrome (PMS), a cluster of recurrent physical, psychological, and emotional symptoms occurring during the late luteal phase and disappearing within a few days of the onset of menses. [2][3][4] As many as 80% of women experience at least one of the PMS symptoms 3,5,6 described in the ICD-10, 7 which include, but are not limited to, mild psychological discomfort, feelings of bloating and weight gain, breast tenderness, swelling of hands and feet, various aches and pains, poor concentration, sleep disturbances, and changes in appetite.Moderate to severe PMS affects 20-35% of women and may cause significant functional impairment and deterioration of interpersonal relationships. 1 In turn, the prevalence of premenstrual dysphoric disorder (PMDD), the most severe form of PMS, has been estimated to vary from 3-8% among women of reproductive age. PMDD is a cyclical disorder closely related to the menstrual cycle, disappearing during pregnancy and after menopause. 8 PMDD has deleterious effects on quality of life (QOL), [9][10][11][12] with a burden similar to that of dysthymia or major depressive disorder. 13,14 The definition of PMDD in both DSM-IV and DSM-5 is based upon a peri-menstrual pattern of at least one among four key affective symptoms (markedly depressed mood, feelings of hopelessness, or self-deprecating thoughts; marked anxiety, tension; marked affective lability; persistent anger or irritability, incr...

show abstract

Section: Discussionmentioning

confidence: 99%

Validation of the Brazilian Portuguese version of the Premenstrual Symptoms Screening Tool (PSST) and association of PSST scores with health-related quality of life

Câmara

Köhler

Frey

et al. 2016

Rev. Bras. Psiquiatr.

View full text Add to dashboard Cite

show abstract

“…Sixth, Yang M, et al (2008) [24] conducted a study about burden of premenstrual dysphoric disorder on health-related quality of life among USA women via internet survey. They concluded that CSPMS had significant impact on the physical wellbeing among their participants especially those who had chronic diseases.…”

Section: Discussionmentioning

confidence: 99%

Quality of Life Among Girls with or Without Clinically Significant Premenstrual Syndrome

Elgzar¹

2017

AJNS

View full text Add to dashboard Cite

Premenstrual syndrome (PMS) is one of the most vague and ill-defined phenomena in the field of woman health.Almost all its definitions concluded that it is a cyclic recurrence of distressing physical, psychological and behavioral symptoms, that occur during the luteal phase of menstrual cycle and evaporates within two days of the onset of menses. PMS may range in its severity from mild (90% of females) to moderate or severe (12.6-31% of females). The last type is called Clinically Significant Premenstrual Syndrome (CSPMS). The emergence of CSPMS during the teen years complicates the process of puberty and assumed to have negative impact on the girl's Health Related Quality of Life (HRQOL). This study aimed to compare HRQOL in the girls with and without CSPMS. This was a comparative study which was carried out on 600 female students (300 free from CSPMS and 300 suffer from CSPMS) at Damanhur University, Elbehira governorate, Egypt. A modified version of Premenstrual Symptoms Screening Tool (PMSST) for clinicians was used to assess the severity of subject's PMS. Each subject was assigned to either CSPMS free group or CSPMS group based on the severity of their PMS symptoms. Then the HRQOL was assessed in the two groups, using a translated version of RAND36-item Health Survey Questionnaire. The study results indicated a statistically significant difference between the two groups in their total quality of life score. The quality of life among the free group was almost equally good or fair while poor quality of life was found among around one tenth (12%) of CSPMS group compared to none among the free group. The largest proportion (86%) among CSPMS group had fair quality of life. The most negatively affected domains were social functioning, role limitations due to physical health, role limitations due to emotional problems, energy/fatigue and emotional well-being respectively. The least affected domains were physical functioning and general health perception. On the other hand, bodily pain wasn't affected at all. The study findings revealed that girls with CSPMS suffer from poorer health-related quality of life than those without CSMPS. Appropriate PMS management strategies should be initiated in order to improve the health related quality of life among girls with CSPMS. The culture of silence surrounding PMS should be broken by focusing on researches that highlight its importance and negative impact on quality of life.

show abstract

“…PMDD has a significant negative impact on quality of life. Yang et al reported that the burden of PMDD on health-related quality of life was greater than the burden associated with back pain, and was similar to Type II diabetes, hypertension, rheumatoid arthritis and somewhat similar to depression [18]. Heinemann, Minh, Filonenko, and Uhl-Hochgraber concluded that PMDD is associated with impaired work productivity and absenteeism, thus resulting in a potential reduction of female economic productivity (19).…”

Section: The Burden Of Illnessmentioning

confidence: 99%

Premenstrual dysphoric disorder and premenstrual syndrome: an overview

Bharti

Kohli

Sharma³

2014

Sri Lanka J. Psyc.

View full text Add to dashboard Cite

Premenstrual dysphoric disorder (PMDD) affects 3-8% of women in the reproductive age group, while premenstrual syndrome (PMS) has a prevalence of 20-30%. PMS and PMDD are associated with significant reduction in quality of life and decreased work productivity. This review examines the current literature regarding the epidemiology, aetiology, diagnosis, burden of illness and management of PMDD and PMS.

show abstract

Burden of Premenstrual Dysphoric Disorder on Health-Related Quality of Life

Abstract: PMDD is associated with substantial burden on both physical and mental aspects of HRQoL.

Cited by 88 publications

References 37 publications

Validation of the Brazilian Portuguese version of the Premenstrual Symptoms Screening Tool (PSST) and association of PSST scores with health-related quality of life

Validation of the Brazilian Portuguese version of the Premenstrual Symptoms Screening Tool (PSST) and association of PSST scores with health-related quality of life

Quality of Life Among Girls with or Without Clinically Significant Premenstrual Syndrome

Premenstrual dysphoric disorder and premenstrual syndrome: an overview

Contact Info

Product

Resources

About